Subscribe to our Newsletters !!
Drug quality is defined not only how a drug is man
Eppendorf is launching the new VisioNize® box 2,
The journey and merging of sperm and egg cells is
This year, the Hamburg based life sciences company
Alembic Pharmaceutica
Since it’s an ingredient in so many foods, you h
Dear Readers,Welcome to the latest issue of Microb
New Delhi, Oct 23 (PTI) Drug firm Zydus Cadila on Friday said it has received approval from the US health regulator to market Albuterol tablets, used to treat shortness of breath caused by breathing problems like asthma. The company has received final approval from the US Food and Drug Administration (USFDA) to market its product, which is a generic version of Proventil tablets, Zydus Cadila said in a statement.
Albuterol is a bronchodilator that can help open up the airways in the lungs to make it easier to breathe. The medication is used to treat and to prevent bronchospasm.
The drug firm said the product could be manufactured at the group”s formula manufacturing center at SEZ, Ahmedabad.
Zydus Cadila now has 310 approvals and thus far filed over 390 abbreviated new drug applications (ANDAs) since the initiation of the filing process in 2003-04. PTI MSS BAL BAL
